Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Seed
Industries
    About
    Syncona, a FTSE 250 healthcare company, creates, builds, and scales global leaders in life science to deliver transformational treatments and maximize value for stakeholders.
    Min check size
    $1M
    Max check size
    $20M
    Fund size
    NPS

    Investment Thesis

    To invest in and build companies around exceptional science, focusing on delivering transformational treatments that extend and enhance human life.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    With a robust background in private equity, the fund manager has successfully executed over 50 deals, primarily in the technology and healthcare sectors across North America and Europe. Emphasizing a thematic investment approach, they prioritize operator-first strategies that enhance portfolio performance. The manager's notable exits include several high-profile IPOs and acquisitions, demonstrating a strong track record in value creation. Their focus on early to growth-stage investments showcases a commitment to fostering innovation while delivering substantial returns.

    Syncona Contacts Information

    Primary contact

    Secondary contact

    Team

    Stephen Molumby

    Siobhan Weaver

    Rolf Soderstrom

    Michael Kyriakides

    Kate Butler

    Fergus Witt

    Annabel Clay

    Amisha Choksi

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp